News
The newly recommended dosing schedule significantly lowered ARIA-E rates compared to the original dosing schedule, adding to the established safety profile of the treatment "We are confident that this ...
At a lymphoma conference, experts sparred about treatment options, while an outside expert highlighted the value of each approach.
Eli Lilly has won a green light from the FDA for new dosing for its Alzheimer's disease therapy Kisunla, which carries a ...
Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...
The symptoms can include nerve pain, emotional numbness and sexual dysfunction and can last for years after stopping the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results